Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation.

Identification of aberrant microRNA (miRNA) expression during chemical carcinogen-induced cell transformation will lead to a better understanding of the substantial role of miRNAs in cancer development. To explore whether aberrant miRNAs expression can be used as biomarkers of chemical exposure in risk assessment of chemical carcinogenesis, we analyzed miRNA expression profiles of human bronchial epithelial cells expressing an oncogenic allele of H-Ras (HBER) at different stages of transformation induced by benzo(a)pyrene (BaP) by miRNA array. It revealed 12 miRNAs differentially expressed in HBER cells at both pretransformed and transformed stages. Differentially expressed miRNAs were confirmed in transformed cells and examined in 50 pairs of primary human non-small-cell lung cancer (NSCLC) tissues using real-time PCR. Among these miRNAs, downregulation of miR-638 was found in 68% (34/50) of NSCLC tissues. However, the expression of miR-638 in HBER cells increased upon treatment of BaP in a dose-dependent manner. The expression of miR-638 was also examined in peripheral lymphocytes from 86 polycyclic aromatic hydrocarbons (PAHs)-exposed (PE) workers. We found that the average expression level of miR-638 in peripheral lymphocytes from 86 PE workers increased by 72% compared with control group. The levels of miR-638 were correlated with the concentration of urinary 1-hydroxypyrene (1-OHP) and external levels of PAHs. Overexpression of miR-638 aggravated cell DNA damage induced by BaP, which might be mediated by suppression of breast cancer 1 (BRCA1), one of the target genes of miR-638. In summary, we suggest that miR-638 is involved in the BaP-induced carcinogenesis by targeting BRCA1.

[1]  Caixia Liu,et al.  Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen , 2011, Oncogene.

[2]  J. Zhao,et al.  α4 is highly expressed in carcinogen-transformed human cells and primary human cancers , 2011, Oncogene.

[3]  Andrew Williams,et al.  Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. , 2011, Mutation research.

[4]  Thomas Manke,et al.  MicroRNAs Differentially Expressed in Postnatal Aortic Development Downregulate Elastin via 3′ UTR and Coding-Sequence Binding Sites , 2011, PloS one.

[5]  Jianbo Wu,et al.  Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide. , 2010, Biochemical and biophysical research communications.

[6]  Kenneth G. Sexton,et al.  Epigenetic Changes Induced by Air Toxics: Formaldehyde Exposure Alters miRNA Expression Profiles in Human Lung Cells , 2010, Environmental health perspectives.

[7]  Shi‐Mei Zhuang,et al.  A novel GSK‐3 beta–C/EBP alpha–miR‐122–insulin‐like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma , 2010, Hepatology.

[8]  P. Sharp,et al.  MicroRNA functions in stress responses. , 2010, Molecular cell.

[9]  Yiguo Jiang,et al.  miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  Tao Chen.  The Role of MicroRNA in Chemical Carcinogenesis , 2010, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[11]  Hyunsoo Kim,et al.  Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. , 2010, Cancer research.

[12]  Muller Fabbri,et al.  Modulation of mismatch repair and genomic stability by miR-155 , 2010, Proceedings of the National Academy of Sciences.

[13]  Yiguo Jiang,et al.  Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. , 2010, Life sciences.

[14]  J. Schwartz,et al.  Exposure to Metal-Rich Particulate Matter Modifies the Expression of Candidate MicroRNAs in Peripheral Blood Leukocytes , 2010, Environmental health perspectives.

[15]  I. Pogribny,et al.  The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. , 2009, Toxicology and applied pharmacology.

[16]  George A Calin,et al.  Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Yiguo Jiang,et al.  MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. , 2009, Biomedical and environmental sciences : BES.

[18]  A. Burny,et al.  Evolution of microRNA expression during human bronchial squamous carcinogenesis , 2008, European Respiratory Journal.

[19]  Ping Yang,et al.  Development of human cell models for assessing the carcinogenic potential of chemicals. , 2008, Toxicology and applied pharmacology.

[20]  J. Jassem,et al.  BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer , 2007, PloS one.

[21]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor plays a significant role in mediating airborne particulate-induced carcinogenesis in mice. , 2007, Environmental science & technology.

[22]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[23]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[24]  R. Landreneau,et al.  Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer. , 2006, The Annals of thoracic surgery.

[25]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[26]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[27]  S. Leng,et al.  Effects of genetic polymorphisms of metabolic enzymes on cytokinesis-block micronucleus in peripheral blood lymphocyte among coke-oven workers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[29]  P. Johnston,et al.  BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. , 2003, Cancer research.

[30]  M. Fenech,et al.  HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. , 2003, Mutation research.

[31]  Y. Nakanishi,et al.  Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. , 2002, Cytokine.

[32]  M. Perricaudet,et al.  BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. , 2000, Cancer research.

[33]  B. Jeffy,et al.  Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. , 2000, Neoplasia.

[34]  B. Jeffy,et al.  Inhibition of BRCA‐1 expression by benzo[a]pyrene and its diol epoxide , 1999, Molecular carcinogenesis.

[35]  R. Anzion,et al.  Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine. , 1986, Scandinavian journal of work, environment & health.

[36]  Yiguo Jiang,et al.  miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  J. Nickoloff,et al.  Regulation of DNA double-strand break repair pathway choice , 2008, Cell Research.

[38]  J. DiGiovanni,et al.  Multistage carcinogenesis in mouse skin. , 1992, Pharmacology & therapeutics.

[39]  R. Anzion,et al.  Biological monitoring of polycyclic aromatic hydrocarbons , 1986 .